Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects.

Jiménez A, Casamitjana R, Flores L, Viaplana J, Corcelles R, Lacy A, Vidal J.

Ann Surg. 2012 Dec;256(6):1023-9. doi: 10.1097/SLA.0b013e318262ee6b.

PMID:
22968072
2.

Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta-analysis of outcomes.

Yip S, Plank LD, Murphy R.

Obes Surg. 2013 Dec;23(12):1994-2003. doi: 10.1007/s11695-013-1030-z. Review.

PMID:
23955521
3.

Effect of sleeve gastrectomy on type 2 diabetes as an alternative treatment modality to Roux-en-Y gastric bypass: systemic review and meta-analysis.

Cho JM, Kim HJ, Lo Menzo E, Park S, Szomstein S, Rosenthal RJ.

Surg Obes Relat Dis. 2015 Nov-Dec;11(6):1273-80. doi: 10.1016/j.soard.2015.03.001. Epub 2015 Mar 5. Review.

PMID:
26071847
4.

Bariatric surgery - effects on obesity and related co-morbidities.

Svane MS, Madsbad S.

Curr Diabetes Rev. 2014 May;10(3):208-14. Review.

PMID:
24934290
5.

Bariatric surgery in patients with type 2 diabetes: benefits, risks, indications and perspectives.

Scheen AJ, De Flines J, De Roover A, Paquot N.

Diabetes Metab. 2009 Dec;35(6 Pt 2):537-43. doi: 10.1016/S1262-3636(09)73463-9. Review.

PMID:
20152741
6.

Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.

Spector D, Shikora S.

Int J Clin Pract Suppl. 2010 Feb;(166):53-8. doi: 10.1111/j.1742-1241.2009.02279.x. Review.

PMID:
20377665
7.

Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis.

Panunzi S, De Gaetano A, Carnicelli A, Mingrone G.

Ann Surg. 2015 Mar;261(3):459-67. doi: 10.1097/SLA.0000000000000863. Review.

PMID:
25361217
8.

Sleeve gastrectomy and Roux En Y gastric bypass: current state of metabolic surgery.

Torgersen Z, Osmolak A, Forse RA.

Curr Opin Endocrinol Diabetes Obes. 2014 Oct;21(5):352-7. doi: 10.1097/MED.0000000000000099. Review.

PMID:
25111943
9.

Current evidence for a role of GLP-1 in Roux-en-Y gastric bypass-induced remission of type 2 diabetes.

Rhee NA, Vilsbøll T, Knop FK.

Diabetes Obes Metab. 2012 Apr;14(4):291-8. doi: 10.1111/j.1463-1326.2011.01505.x. Epub 2011 Nov 13. Review.

PMID:
21951387
10.

Diabetes remission following metabolic surgery: is GLP-1 the culprit?

Vidal J, Jiménez A.

Curr Atheroscler Rep. 2013 Oct;15(10):357. doi: 10.1007/s11883-013-0357-1. Review.

PMID:
23955665
11.
12.

Metabolic Surgery in Type 2 Diabetes: Roux-en-Y Gastric Bypass or Sleeve Gastrectomy as Procedure of Choice?

Vidal J, Jiménez A, de Hollanda A, Flores L, Lacy A.

Curr Atheroscler Rep. 2015 Oct;17(10):58. doi: 10.1007/s11883-015-0538-1. Review.

PMID:
26303455
13.

Impact of roux-en Y gastric bypass surgery on prognostic factors of type 2 diabetes mellitus: meta-analysis and systematic review.

Chen Y, Zeng G, Tan J, Tang J, Ma J, Rao B.

Diabetes Metab Res Rev. 2015 Oct;31(7):653-62. doi: 10.1002/dmrr.2622. Epub 2014 Dec 17. Review.

PMID:
25387821
14.

Clinical considerations for the management of residual diabetes following bariatric surgery.

Kashyap SR, Schauer P.

Diabetes Obes Metab. 2012 Sep;14(9):773-79. doi: 10.1111/j.1463-1326.2012.01577.x. Epub 2012 Feb 21. Review.

PMID:
22288474
15.

Impact of gastrointestinal surgery on cardiometabolic risk.

Moustarah F, Gilbert A, Després JP, Tchernof A.

Curr Atheroscler Rep. 2012 Dec;14(6):588-96. doi: 10.1007/s11883-012-0288-2. Review.

PMID:
23054664
16.

Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index <35 kg/m2: a literature review.

Reis CE, Alvarez-Leite JI, Bressan J, Alfenas RC.

Diabetes Technol Ther. 2012 Apr;14(4):365-72. doi: 10.1089/dia.2011.0127. Epub 2011 Dec 16. Review.

PMID:
22176155
17.

Comparison of the long-term results of Roux-en-Y gastric bypass and sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis of randomized and nonrandomized trials.

Li JF, Lai DD, Lin ZH, Jiang TY, Zhang AM, Dai JF.

Surg Laparosc Endosc Percutan Tech. 2014 Feb;24(1):1-11. doi: 10.1097/SLE.0000000000000041. Review.

PMID:
24487151
18.

Bariatric surgery versus medications in the treatment of type 2 diabetes.

Fanin A, Benetti A, Ceriani V, Pontiroli AE.

Minerva Endocrinol. 2015 Dec;40(4):297-306. Epub 2015 Sep 10. Review.

PMID:
26365477
19.

Metabolic surgery, weight regain and diabetes re-emergence.

Campos JM, Lins DC, Silva LB, Araujo-Junior JG, Zeve JL, Ferraz ÁA.

Arq Bras Cir Dig. 2013;26 Suppl 1:57-62. Review. English, Portuguese.

20.

A meta-analysis of short-term outcomes of patients with type 2 diabetes mellitus and BMI ≤ 35 kg/m2 undergoing Roux-en-Y gastric bypass.

Rao WS, Shan CX, Zhang W, Jiang DZ, Qiu M.

World J Surg. 2015 Jan;39(1):223-30. doi: 10.1007/s00268-014-2751-4. Review.

PMID:
25159119

Supplemental Content

Support Center